Although CD11c+ cells were present in both the control and the STZ groups around the tumors, as assessed by immunohistochemistry (Fig. 3B), the number of tumor-infiltrating CD11c+ cells was significantly lower in the STZ than in the control groups (Fig. 3B,C). The gene discussed is ITGAX; the disease is neoplasm.